We are live on
!
Find out more
OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
0 hedge funds and large institutions have $0 invested in OncoMed Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 41 → 0 (-41)
100% less capital invested
Capital invested by funds: $16.9M → $0 (-$16.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 41
Holders
–
Holders Change
-41
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
41
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Primecap Management
Pasadena,
California
|
-$5.67M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.27M |
| 3 |
Renaissance Technologies
New York
|
-$1.88M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.79M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$395K |
